Raymond James & Associates’s UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN MLPL Stock Holding History
Bought
Maintained
Sold
Other funds holding MLPL
EGA
PCM
SCA
ACP
BGA
CFA
VF
ST
RIG
Raymond James & Associates's MLPL Position: Q2 2015 in Review
Raymond James & Associates sold out of UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN (MLPL) in Q2 2015, closing a stake of 10,091 shares — an estimated $508K sold.
Raymond James & Associates first reported a position in MLPL in Q4 2014 and held it in 2 quarters. The position peaked at $993K in Q4 2014. 21 funds tracked by Wall St. Rank hold MLPL as of Q2 2015.
- Raymond James & Associates reported no remaining UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position as of Q2 2015 after selling out during the quarter.
- Raymond James & Associates sold 10,091 UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN shares in Q2 2015, an estimated $508K.
- Raymond James & Associates first reported a position in UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN in Q4 2014 and held it in 2 quarters.
- Raymond James & Associates's UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position peaked at $993K in Q4 2014.
- 21 funds tracked by Wall St. Rank held UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN as of Q2 2015.
Based on Raymond James & Associates's 13F filing for Q2 2015, filed 13 Aug 2015.